Clinical Trials Browser

Breast Neoplasms

Liposarcoma, Liposarcoma, Myxoid

Brain Neoplasms

Leukemia, Myeloid, Acute

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Breast Neoplasms

Melanoma, Neoplasms, Pancreatic Neoplasms

EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor

Glioblastoma, Recurrence

Solid Tumors Refractory to Standard Therapy

Solid Tumor, Adult

Breast Neoplasms, Neoplasm, Residual

Advanced HR - Positive, HER2 - Negative Breast Cancer

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Esophageal Squamous Cell Carcinoma

ER+ Breast Cancer

Breast Neoplasms, Inflammation, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

Colorectal Neoplasms

Clinical Trials

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Tazemetostat and Palbociclib With CPX-351for R/R AML

TAPUR

PAveMenT

Combined Immunotherapies in Metastatic ER+ Breast Cancer

A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

APEAK

Palbociclib and Pembrolizumab in Sarcoma

Pilot Trial for Treatment of Recurrent Glioblastoma

COPS-01

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

PALAVY

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

PLATFORM Study of Precision Medicine for Rare Tumors

PALMARES-2

Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas

TRAK-ER

PTST_PALBEVA

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

ORACLE-RIPA

EVIDENT